Atlas FRM LLC lifted its holdings in Suzano S.A. (NYSE:SUZ - Free Report) by 13.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,320,000 shares of the company's stock after acquiring an additional 2,000,000 shares during the quarter. Suzano makes up approximately 16.5% of Atlas FRM LLC's holdings, making the stock its 3rd largest holding. Atlas FRM LLC owned about 1.31% of Suzano worth $175,278,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of SUZ. GAMMA Investing LLC raised its holdings in Suzano by 58.2% during the 4th quarter. GAMMA Investing LLC now owns 2,791 shares of the company's stock worth $28,000 after purchasing an additional 1,027 shares during the last quarter. Lindbrook Capital LLC grew its holdings in Suzano by 69.2% during the fourth quarter. Lindbrook Capital LLC now owns 3,004 shares of the company's stock valued at $30,000 after purchasing an additional 1,229 shares during the period. Blue Trust Inc. increased its stake in Suzano by 222.7% in the fourth quarter. Blue Trust Inc. now owns 6,592 shares of the company's stock valued at $67,000 after purchasing an additional 4,549 shares in the last quarter. Signaturefd LLC boosted its position in shares of Suzano by 28.9% during the fourth quarter. Signaturefd LLC now owns 7,969 shares of the company's stock worth $81,000 after purchasing an additional 1,787 shares in the last quarter. Finally, US Bancorp DE grew its holdings in shares of Suzano by 20.3% in the 4th quarter. US Bancorp DE now owns 9,177 shares of the company's stock valued at $93,000 after buying an additional 1,547 shares during the period. Institutional investors own 2.55% of the company's stock.
Suzano Stock Up 2.0 %
Shares of SUZ traded up $0.18 on Friday, hitting $8.97. The company's stock had a trading volume of 1,580,594 shares, compared to its average volume of 2,009,891. The company has a quick ratio of 1.40, a current ratio of 1.72 and a debt-to-equity ratio of 2.81. The firm has a market capitalization of $11.88 billion, a price-to-earnings ratio of 14.24 and a beta of 0.94. The firm's fifty day moving average price is $9.21 and its 200-day moving average price is $9.93. Suzano S.A. has a fifty-two week low of $8.41 and a fifty-two week high of $11.93.
Analyst Ratings Changes
Separately, UBS Group upgraded Suzano to a "strong-buy" rating in a report on Thursday, April 10th.
Check Out Our Latest Report on SUZ
Suzano Company Profile
(
Free Report)
Suzano SA produces and sells eucalyptus pulp and paper products in Brazil and internationally. It operates through Pulp and Paper segments. The company offers coated and uncoated printing and writing papers, paperboards, tissue papers, and market and fluff pulps; and lignin. It also engages in the research, development, and production of biofuel; operation of port terminals; power generation and distribution business; commercialization of equipment and parts; industrialization, commercialization, and exporting of pulp and standing wood; road freight transport; biotechnology research and development; and commercialization of paper and computer materials.
Featured Stories

Before you consider Suzano, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Suzano wasn't on the list.
While Suzano currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.